Cargando…
Engineering of chitosan and collagen macromolecules using sebacic acid for clinical applications
Transformation of natural polymers to three-dimensional (3D) scaffolds for biomedical applications faces a number of challenges, viz., solubility, stability (mechanical and thermal), strength, biocompatibility, and biodegradability. Hence, intensive research on suitable agents to provide the requisi...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5151108/ https://www.ncbi.nlm.nih.gov/pubmed/29470652 http://dx.doi.org/10.1186/2194-0517-2-11 |
_version_ | 1782474325842984960 |
---|---|
author | Sailakshmi, G Mitra, Tapas Gnanamani, A |
author_facet | Sailakshmi, G Mitra, Tapas Gnanamani, A |
author_sort | Sailakshmi, G |
collection | PubMed |
description | Transformation of natural polymers to three-dimensional (3D) scaffolds for biomedical applications faces a number of challenges, viz., solubility, stability (mechanical and thermal), strength, biocompatibility, and biodegradability. Hence, intensive research on suitable agents to provide the requisite properties has been initiated at the global level. In the present study, an attempt was made to engineer chitosan and collagen macromolecules using sebacic acid, and further evaluation of the mechanical stability and biocompatible property of the engineered scaffold material was done. A 3D scaffold material was prepared using chitosan at 1.0% (w/v) and sebacic acid at 0.2% (w/v); similarly, collagen at 0.5% (w/v) and sebacic acid at 0.2% (w/v) were prepared individually by freeze-drying technique. Analysis revealed that the engineered scaffolds displayed an appreciable mechanical strength and, in addition, were found to be biocompatible to NIH 3T3 fibroblast cells. Studies on the chemistry behind the interaction and the characteristics of the cross-linked scaffold materials suggested that non-covalent interactions play a major role in deciding the property of the said polymer materials. The prepared scaffold was suitable for tissue engineering application as a wound dressing material. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/2194-0517-2-11) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5151108 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-51511082016-12-27 Engineering of chitosan and collagen macromolecules using sebacic acid for clinical applications Sailakshmi, G Mitra, Tapas Gnanamani, A Prog Biomater Original Research Transformation of natural polymers to three-dimensional (3D) scaffolds for biomedical applications faces a number of challenges, viz., solubility, stability (mechanical and thermal), strength, biocompatibility, and biodegradability. Hence, intensive research on suitable agents to provide the requisite properties has been initiated at the global level. In the present study, an attempt was made to engineer chitosan and collagen macromolecules using sebacic acid, and further evaluation of the mechanical stability and biocompatible property of the engineered scaffold material was done. A 3D scaffold material was prepared using chitosan at 1.0% (w/v) and sebacic acid at 0.2% (w/v); similarly, collagen at 0.5% (w/v) and sebacic acid at 0.2% (w/v) were prepared individually by freeze-drying technique. Analysis revealed that the engineered scaffolds displayed an appreciable mechanical strength and, in addition, were found to be biocompatible to NIH 3T3 fibroblast cells. Studies on the chemistry behind the interaction and the characteristics of the cross-linked scaffold materials suggested that non-covalent interactions play a major role in deciding the property of the said polymer materials. The prepared scaffold was suitable for tissue engineering application as a wound dressing material. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/2194-0517-2-11) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2013-04-23 /pmc/articles/PMC5151108/ /pubmed/29470652 http://dx.doi.org/10.1186/2194-0517-2-11 Text en © Sailakshmi et al.; licensee Springer. 2013 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Research Sailakshmi, G Mitra, Tapas Gnanamani, A Engineering of chitosan and collagen macromolecules using sebacic acid for clinical applications |
title | Engineering of chitosan and collagen macromolecules using sebacic acid for clinical applications |
title_full | Engineering of chitosan and collagen macromolecules using sebacic acid for clinical applications |
title_fullStr | Engineering of chitosan and collagen macromolecules using sebacic acid for clinical applications |
title_full_unstemmed | Engineering of chitosan and collagen macromolecules using sebacic acid for clinical applications |
title_short | Engineering of chitosan and collagen macromolecules using sebacic acid for clinical applications |
title_sort | engineering of chitosan and collagen macromolecules using sebacic acid for clinical applications |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5151108/ https://www.ncbi.nlm.nih.gov/pubmed/29470652 http://dx.doi.org/10.1186/2194-0517-2-11 |
work_keys_str_mv | AT sailakshmig engineeringofchitosanandcollagenmacromoleculesusingsebacicacidforclinicalapplications AT mitratapas engineeringofchitosanandcollagenmacromoleculesusingsebacicacidforclinicalapplications AT gnanamania engineeringofchitosanandcollagenmacromoleculesusingsebacicacidforclinicalapplications |